Bad Blood by John Carreyrou audiobook

Bad Blood: Secrets and Lies in a Silicon Valley Startup

By John Carreyrou
Read by  Will Damron

Random House Audio

Unabridged

Format: Library CD (In Stock)
  • ISBN: 9780593105061

  • ISBN: 9780593105061

Runtime: 11.61 Hours
Category: Nonfiction
Audience: Adult
Language: English

Summary

Summary

New York Times bestseller

A #1 New York Times audio bestseller

Audible.com Best of the Year in Nonfiction

A 2018 Time Magazine Top 10 Books of the Year selection in Nonfiction

Finalist for the Los Angeles Times Book Prize for Biography

An Esquire Magazine Pick of Best Books of 2018 (So Far)

A Variety Magazine Pick of 3 Books to Read If You Were Glued to the Elizabeth Holmes Documentary

An iBooks bestseller in Audiobooks

A Paste Magazine Pick of Best Nonfiction Books of 2018

A New York Post Pick of 2018's Best Books

An Amazon Best Book of the Month selection

A Kirkus Reviews Pick of 10 Excellent Summer Reads

NEW YORK TIMES BEST SELLER •  NAMED ONE OF THE BEST BOOKS OF THE YEAR BY: NPR, The New York Times Book Review, Time, Wall Street Journal, Washington Post • The McKinsey Business Book of the Year
 
The full inside story of the breathtaking rise and shocking collapse of Theranos, the one-time multibillion-dollar biotech startup founded by Elizabeth Holmes—now the subject of the HBO documentary The Inventor—by the prize-winning journalist who first broke the story and pursued it to the end.

“The story is even crazier than I expected, and I found myself unable to put it down once I started. This book has everything: elaborate scams, corporate intrigue, magazine cover stories, ruined family relationships, and the demise of a company once valued at nearly $10 billion.” —Bill Gates


In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.7 billion. There was just one problem: The technology didn’t work.

A riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley.

Editorial Reviews

Editorial Reviews

Engrossing… Bad Blood boasts movie-scene detail… Theranos, Carreyrou writes, was a revolving door, as Holmes and Balwani fired anyone who voiced even tentative doubts… What’s frightening is how easy it is to imagine a different outcome, one in which the company’s blood-testing devices continued to proliferate. That the story played out as it did is a testament to the many individuals who spoke up, at great personal risk. Jennifer Couzin-Frankel, Science
In Bad Blood, acclaimed investigative journalist John Carreyrou, who broke the story in 2015, presents comprehensive evidence of the fraud perpetrated by Theranos chief executive Elizabeth Holmes... He unveils many dark secrets of Theranos that have not previously been laid bare…  The combination of these brave whistle-blowers, and a tenacious journalist who interviewed 150 people (including 60 former employees) makes for a veritable page-turner. Eric Topol, Nature
"In exposing the fudged numbers, boardroom battles and sickening sums of money tossed Theranos’ way, Bad Blood succeeds in highlighting Silicon Valley’s paradoxical blind spot. Insular corporate culture and benevolent media coverage have allowed a monster to grow in the Valley—one that gambles not just with our smart phones or our democracy, but with people’s lives. Bad Blood reveals a crucial truth: outside observers must act as the eyes, the ears and, most importantly, the voice of Silicon Valley’s blind spot. B. David Zarley, Paste Magazine's "16 Best Nonfiction Books of 2018
Carreyrou blends lucid descriptions of Theranos’s technology and its failures with a vivid portrait of its toxic culture and its supporters’ delusional boosterism. The result is a bracing cautionary tale about visionary entrepreneurship gone very wrong. Publishers Weekly (Starred)
Eye-opening... A vivid, cinematic portrayal of serpentine Silicon Valley corruption... A deep investigative report on the sensationalistic downfall of multibillion-dollar Silicon Valley biotech startup Theranos. Basing his findings on hundreds of interviews with people inside and outside the company, two-time Pulitzer Prize-winning Wall Street Journal reporter Carreyrou rigorously examines the seamy details behind the demise of Theranos and its creator, Elizabeth Holmes… [Carreyrou] brilliantly captures the interpersonal melodrama, hidden agendas, gross misrepresentations, nepotism, and a host of delusions and lies that further fractured the company’s reputation and halted its rise. Kirkus
Crime thriller authors have nothing on Carreyrou's exquisite sense of suspenseful pacing and multifaceted character development in this riveting, read-in-one-sitting tour de force.... Carreyrou's commitment to unraveling Holmes' crimes was literally of life-saving value. Booklist (Starred Review)
Even if you didn’t follow the story of charismatic Theranos founder Elizabeth Holmes (and the ensuing trainwreck) in the news, you will find yourself zipping through a book that proves once again that fact is stranger than fiction. A stunning look into a high-tech hoodwinking; like a high-speed car chase in a book. The New York Post's "28 Most Unforgettable Books of 2018"
A great and at times almost unbelievable story of scandalous fraud, surveillance, and legal intimidation at the highest levels of American corporate power. . . . The story of Theranos may be the biggest case of corporate fraud since Enron. But it’s also the story of how a lot of powerful men were fooled by a remarkably brazen liar. Yashar Ali, New York Magazine
Bad Blood is the real be-all end-all of Theranos information…. Bad Blood is wild, and more happens on one page than in many other entire books. Margaret Lyons, The New York Times
You will not want to put this riveting, masterfully reported book down. No matter how bad you think the Theranos story was, you'll learn that the reality was actually far worse. Bethany McLean, bestselling coauthor of The Smartest Guys in the Room and All the Devils Are Here
Chilling... Carreyrou tells [this story] virtually to perfection… Reads like a West Coast version of All the President's Men. Roger Lowenstein, The New York Times Book Review
The definitive account of Theranos’s downfall, detailing its motley crew of executives, legal knife fights, dramatic PR stunts, and skullduggery... Offers a lot for foreign-policy wonks... While Bad Blood is worth reading for its own merits—it’s a stunning feat of journalism that reads like a thriller—it also says a lot about Washington’s facile relationship with Silicon Valley. Most D.C. power brokers know next to nothing about science or technology but increasingly view Silicon Valley tech as a deus ex machina for some of the world’s most complicated challenges. Bad Blood offers a sobering warning of where that type of thinking can lead. Robbie Gramer, Foreign Policy
“Will Damron is the perfect choice as narrator. His precisely articulated style makes the entire effort sound as if it is a cloak-and-dagger spy novel.” AudioFile
“[A] gripping listen. Bad Blood reads like a thriller. It’s filled with detailed descriptions of the secrecy and lies that made a company that seemed to be have everything—life-saving technology’ a young, inspiring, and media-catnip female CEO; and a billion-dollar valuation—come crumbling down. I’m recommending this nonfiction book to everyone this year—even my never-nonfiction friends.” Audible.com

Reviews

Reviews

Author

Author Bio: John Carreyrou

Author Bio: John Carreyrou

John Carreyrou is a two-time Pulitzer-prize winning investigative reporter at the Wall Street Journal. For his extensive coverage of Theranos, Inc., he was awarded the George Polk Award for Financial Reporting, the Gerald Loeb Award for Distinguished Business and Financial Journalism, and the Barlett & Steele Award for Investigative Journalism in 2016.

Titles by Author

Details

Details

Available Formats : CD, Library CD
Category: Nonfiction
Runtime: 11.61
Audience: Adult
Language: English